Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  KSP inhibitor ARRY-520
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
KSP Inhibitor ARRY-520 and Carfilzomib in Treating Patients with Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2011-0144, NCI-2011-01120, NCT01372540
Start Over